Clinical and demographic predictors | Beta | Odds Ratio (95% CI) |
---|---|---|
Sex (Male) | 0.36 | 1.44 (1.39–1.48) |
Racea | ||
White | 1.00 | reference |
African-American | 0.17 | 1.19 (1.12–1.25) |
Asian | −0.10 | 0.91 (0.87–0.95) |
Hispanic | 0.18 | 1.20 (1.15–1.25) |
Other/unknown | −0.01 | 0.99 (0.93–1.05) |
Gestational age, wk | ||
32–33 | 0.45 | 1.57 (1.39–1.77) |
34–36 | 0.27 | 1.32 (1.24–1.40) |
37 | 0.14 | 1.15 (1.08–1.22) |
38–40 | 1.00 | reference |
≥41 | −0.06 | 0.95 (0.90–0.99) |
Small for gestational ageb | 0.16 | 1.17 (1.03–1.32) |
Congenital anomaly presentc | 0.13 | 1.14 (1.08–1.21) |
Family history of asthmad | ||
None | 1.00 | |
Father only | 0.16 | 1.17 (1.04–1.32) |
Mother only | 0.37 | 1.45 (1.35–1.56) |
Both parents | 0.38 | 1.46 (0.94–2.29) |
≥1 sibling <5 y of age in home | 0.33 | 1.39 (1.35–1.44) |
O2 exposure and BPDe | ||
No O2 exposure, no BPD | 1.00 | reference |
<200 hr O2, no BPD | 0.17 | 1.19 (1.10–1.29) |
≥200 hr O2, no BPD | 0.58 | 1.79 (1.46–2.20) |
BPDf | 0.28 | 1.33 (0.80–2.19) |
Maternal age, y | ||
<18 | 0.09 | 1.10 (0.96–1.25) |
18–34 | 1.00 | reference |
≥35 | −0.11 | 0.90 (0.86–0.93) |